NDC 50090-0413

Cytomel

Liothyronine Sodium

Cytomel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Liothyronine Sodium.

Product ID50090-0413_dba226d2-0d68-401e-a4f7-ac27410af1c0
NDC50090-0413
Product TypeHuman Prescription Drug
Proprietary NameCytomel
Generic NameLiothyronine Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1956-05-08
Marketing CategoryNDA / NDA
Application NumberNDA010379
Labeler NameA-S Medication Solutions
Substance NameLIOTHYRONINE SODIUM
Active Ingredient Strength5 ug/1
Pharm Classesl-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 50090-0413-5

120 TABLET in 1 BOTTLE (50090-0413-5)
Marketing Start Date2016-06-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0413-5 [50090041305]

Cytomel TABLET
Marketing CategoryNDA
Application NumberNDA010379
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-29
Marketing End Date2019-03-31

Drug Details

Active Ingredients

IngredientStrength
LIOTHYRONINE SODIUM5 ug/1

OpenFDA Data

SPL SET ID:b5cb71c4-0a07-4ac5-b47a-bf46295b4e25
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 903456
  • 903458

    • Pharmacological Class

    • l-Triiodothyronine [EPC]
    • Triiodothyronine [CS]

    NDC Crossover Matching brand name "Cytomel" or generic name "Liothyronine Sodium"

    NDCBrand NameGeneric Name
    50090-0413Cytomelliothyronine sodium
    60793-116CytomelCytomel
    60793-115CytomelCytomel
    60793-117CytomelCytomel
    43742-0956LiothyronineLiothyronine Sodium
    0093-2178Liothyronine SodiumLiothyronine Sodium
    0093-2179Liothyronine SodiumLiothyronine Sodium
    0093-2180Liothyronine SodiumLiothyronine Sodium
    0179-0238Liothyronine SodiumLiothyronine Sodium
    0574-0220Liothyronine SodiumLiothyronine Sodium
    0574-0222Liothyronine SodiumLiothyronine Sodium
    0574-0223Liothyronine SodiumLiothyronine Sodium
    16714-166Liothyronine sodiumLiothyronine sodium
    16714-167Liothyronine sodiumLiothyronine sodium
    16714-168Liothyronine sodiumLiothyronine sodium
    33261-964Liothyronine SodiumLiothyronine Sodium
    39822-0151Liothyronine SodiumLiothyronine Sodium
    42291-417Liothyronine SodiumLiothyronine Sodium
    42291-418Liothyronine SodiumLiothyronine Sodium
    42291-419Liothyronine SodiumLiothyronine Sodium
    42794-018Liothyronine SodiumLiothyronine Sodium
    42794-019Liothyronine SodiumLiothyronine Sodium
    42794-020Liothyronine SodiumLiothyronine Sodium
    43063-252Liothyronine SodiumLiothyronine Sodium
    43063-253Liothyronine SodiumLiothyronine Sodium
    43063-884Liothyronine SodiumLiothyronine Sodium
    50090-3131Liothyronine SodiumLiothyronine Sodium
    50090-5586Liothyronine sodiumLiothyronine sodium
    42023-120Triostatliothyronine sodium

    Trademark Results [Cytomel]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CYTOMEL
    CYTOMEL
    75274531 2167335 Live/Registered
    KING PHARMACEUTICALS RESEARCH AND DEVELO
    1997-04-14
    CYTOMEL
    CYTOMEL
    71698555 0637941 Dead/Expired
    SMITH KLINE & FRENCH LABORATORIES
    1955-11-18
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.